More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA...
More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making
While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized. Ev...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
GETREAL
Incorporating real-life clinical data into drug development
17M€
Cerrado
EU2P
European programme in Pharmacovigilance and Pharmacoepidemio...
8M€
Cerrado
ERAMET
Ecosystem for rapid adoption of modelling and simulation MET...
4M€
Cerrado
HTx
Next Generation Health Technology Assessment to support pati...
10M€
Cerrado
EHR4CR
Electronic Health Record systems for Clinical Research
17M€
Cerrado
FFI2017-83543-P
ESTANDARES DE PRUEBA Y ELECCIONES METODOLOGICAS EN LA FUNDAM...
18K€
Cerrado
Información proyecto More-EUROPA
Duración del proyecto: 61 meses
Fecha Inicio: 2022-11-24
Fecha Fin: 2027-12-31
Descripción del proyecto
While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized. Evidence, based on RWD – real world evidence (RWE) - can contribute significantly to the evidence to support decision making throughout all phases of (clinical) drug development, as well as improve efficiency in design and conduct of clinical trial programs.
The aim of this project is to develop, implement and establish evidentiary standards and methods to address the data and evidentiary needs of regulatory authorities and HTA bodies towards a more efficient use of RWD for the development, registration and assessment of medicinal products in Europe (More-EUROPA).